Global Dermatologicals Market Size, Share, Forecast Report, 2020-2027

The global dermatologicals market accounted for $15,563 million in 2018 and is expected to reach $36,205 million by 2026, registering a CAGR of 10.9% from 2019 to 2026.

Dermatology is a field of medicine that is engaged in the diagnosis, prevention, and treatment of various diseases related to skin, nails, and hair, such as pigmentation, acne, wrinkles, and psoriasis. Dermatological agents, also known as dermatologicals, are products which are applied topically on the skin. These products are used to treat skin conditions and are also employed to prevent certain skin disorders. Furthermore, dermatologicals are also used for routine skin care to maintain one’s skin. However, some of the dermatologicals are systemic preparations, which are used in patients who are not responsive to topical medications. Moreover, these preparations are used to treat various skin conditions such as acne, dermatitis, and psoriasis.
The major factor that contributes to the growth of dermatologicals market include rise in demand for topical dermatological drugs such as anti-inflammatory agents, anti-infective, local anesthetics, cleansers, and emollients to treat acne. Furthermore, the rise in awareness about skin diseases, high demand for rapid diagnosis, and surge in incidence of skin cancer and other skin disorders are the factors that boost the growth of the dermatologicals market. However, lack of awareness about the drugs and stringent government regulations restrain the dermatologicals market growth. The development of innovative products and increase in number of mergers & acquisitions by key vendors are expected to provide numerous opportunities for the market growth during the forecast period.

Dermatologicals Market Segmentation

The dermatologicals market size is studied on the basis of dermatological disease, drug type, route of administration, and region to provide a detailed assessment of the market. On the basis of dermatological disease, it is segmented into acne, dermatitis, psoriasis, skin cancer, rosacea, and alopecia. By drug type, it is bifurcated into prescription-based drugs and over-the-counter drugs. On the basis of route of administration, it is segmented into topical, oral, and parenteral administration. Region wise, it is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, and rest of LAMEA).

Segment Review

According to dermatological disease, the psoriasis segment occupied the largest dermatologicals market share in 2018. Furthermore, it is also expected to be the fastest growing segment during the forecast period. The growth of this segment is attributed to surge in the incidence of psoriasis worldwide. Furthermore, rise in awareness related to the use of topical ointments for the management and treatment of psoriasis is another major factor that drives the growth of the dermatologicals market.
By drug type, the prescription segment occupied the largest share, owing to surge in skin disorders. Furthermore, skin disorders are severe and require skilled medical attention, which is provided by skin specialists. Moreover, over-the-counter drugs is expected to be the fastest growing segment during the forecast period due to surge in the awareness among general public regarding the availability of dermatologicals.
By region, North America accounted for the major dermatologicals market share in 2018 and is expected to continue this trend, owing to easy availability of dermatologicals. Moreover, surge in the incidence of skin disorders such as dermatitis, acne, and psoriasis, is another major reason that contributes to the growth of this dermatologicals market. On the other side, Asia-Pacific is estimated to register the fastest growth during the forecast period attributed to the increase in awareness regarding the use of dermatologicals. The constantly evolving life science industry drives the growth of the market in developing economies such as India, China, and Malaysia. As the constant development leads to surge in awareness related to the use of dermatologicals. Furthermore, it also leads to rise in aesthetic consciousness among people which contributes to the growth of the dermatologicals market.
The global dermatologicals market is highly competitive and the prominent players in the market have adopted various strategies to garner maximum market share. These include collaboration, product launch, partnership, and acquisition. Major players operating in the market include Bayer AG, Johnson & Johnson, Pfizer Inc., Novartis AG, GlaxoSmithKline plc, AstraZeneca, Galderma S.A., Amgen Inc., AbbVie Inc., and Merck KGaA.

Key Benefits for Stakeholders:

• This report entails a detailed quantitative analysis along with the current global dermatologicals market trends from 2018 to 2026 to identify the prevailing opportunities along with the strategic assessment.
• The dermatologicals market forecast is studied from 2019 to 2026. 
• The dermatologicals market size and estimations are based on a comprehensive analysis of key developments in the industry. 
• A qualitative analysis based on innovative products facilitates strategic business planning.
• The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the market

Key Market Segments:

By Dermatological Disease

• Acne
• Dermatitis
• Psoriasis 
• Skin Cancer 
• Rosacea 
• Alopecia 

By Drug Type

• Prescription-Based Drugs 
• Over-the-Counter Drugs

By Route of Administration

• Topical
• Oral
• Parenteral Administration

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany 
  • France 
  • UK 
  • Italy
  • Spain
  • Rest of Europe
• Asia-Pacific
  • Japan 
  • China 
  • India 
  • Australia 
  • South Korea
  • Rest of Asia-Pacific
• LAMEA
  • Brazil
  • Saudi Arabia 
  • South Africa
  • Rest of LAMEA